The Novo Nordisk Foundation supports open competition grants in health and life sciences, which aligns with the venture's AI/biotech focus on drug resistance prediction. However, the programme is broad and competitive; the venture's early stage and lack of incorporation may be a challenge, but the strong proof-of-concept and EU geography fit well.